An adaptive randomized clinical trial in interstitial cystitis/bladder pain syndrome evaluating efficacy of ASP3652 and the relationship between disease characteristics and Hunner’s lesions

被引:0
作者
Jos G. A. Houbiers
J. W. Olivier van Till
Mathilde Kaper
Yalcin Yavuz
Reynaldo V. Martina
Dirk Cerneus
Joost Melis
Otto Stroosma
J. Curtis Nickel
Phil M. Hanno
Jørgen Nordling
机构
[1] Astellas Pharma Europe B.V,Department of Urology
[2] Queens University,Department of Urology
[3] Stanford University,Department of Urology
[4] University of Copenhagen,undefined
[5] Astellas Pharma Inc,undefined
来源
World Journal of Urology | 2021年 / 39卷
关键词
Interstitial cystitis; Phenotype; Fatty acid amide hydrolase (FAAH) inhibitor; Endocannabinoids; Hunner’s lesion; Patient characteristics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2065 / 2071
页数:6
相关论文
共 165 条
[1]  
Van de Merwe JP(2008)Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal Eur Urol 53 60-67
[2]  
Nordling J(2015)Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment J Urol 193 1545-1553
[3]  
Bouchelouche P(2017)The burden of bladder pain in five European countries: a cross-sectional study Urology 99 84-91
[4]  
Bouchelouche K(2014)Phenotype-directed management of interstitial cystitis/bladder pain syndrome Urology 84 175-179
[5]  
Cervigni M(2014)Interstitial cystitis is bladder pain syndrome with Hunner’s lesion Int J Urol 21 79-82
[6]  
Daha LK(2015)Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis? J Urol 193 1994-2000
[7]  
Elneil S(2001)The neurobiology and evolution of cannabinoid signalling Philos Trans R Soc Lond B Biol Sci 356 381-408
[8]  
Fall M(2011)Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation BJU Int 108 1145-1149
[9]  
Hohlbrugger G(2007)The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview Am J Ther 14 475-483
[10]  
Irwin P(2017)Fatty acid amide hydrolase inhibitor treatment in men with chronic prostatitis/chronic pelvic pain syndrome: an adaptive double-blind, randomized controlled trial Urology 103 191-197